Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.56 |
| ▸ | CES1 | P23141 | 4/20 | 0.56 |
| ▸ | GSK3B | P49841 | 7/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA4 | P22748 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | TTR | P02766 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18355570 | 0.83 | GSK3B (0.43) | CES2CES1GSK3BALDH1A1HIF1A | |
| SCHEMBL3093741 | 0.79 | CES2 (0.54) | CES2CES1GSK3BALDH1A1HIF1A | |
| SCHEMBL10373277 | 0.79 | CES2 (0.58) | CES2CES1CA1CA2CA4 | |
| SCHEMBL247898 | 0.78 | CES2 (0.59) | CES2CES1GSK3BALDH1A1HIF1A | |
| SCHEMBL29464070 | 0.78 | CES2 (0.59) | CES2CES1GSK3BALDH1A1HIF1A | |
| SCHEMBL8755885 | 0.78 | GSK3B (0.43) | GSK3BALDH1A1HIF1AMAPK1TRPA1 | |
| SCHEMBL3547368 | 0.77 | CES2 (0.56) | CES2CES1ALDH1A1POLBMAPT | |
| SCHEMBL1849394 | 0.77 | CES2 (0.56) | CES2CES1GSK3BCA1CA2 | |
| SCHEMBL5455143 | 0.75 | KDM4E (0.49) | CES2CES1GSK3BALDH1A1HIF1A | |
| Hydrochloric Acid SCHEMBL3941502 | 0.75 | CES2 (0.55) | CES2CES1GSK3BALDH1A1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120225777-A1 | Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi and Compositions Comprising Them | BASF SE (DE) | 2012-09-06 | — | — | US | disclosed |
| US-20100167924-A1 | Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi and Compositions Comprising Them | BASF SE (DE) | 2010-07-01 | — | — | US | disclosed |
| EP-2035414-B1 | AZOLYLMETHYLOXIRANES, THEIR USE FOR CONTROLLING PHYTOPATHOGENIC FUNGI AND COMPOSITIONS COMPRISING THEM | BASF SE (DE) | 2009-12-16 | — | — | EP | disclosed |
| WO-2009071450-A1 | FUNGICIDAL MIXTURE | BASF SE (DE) | 2009-06-11 | — | — | WO | disclosed |
| EP-2035414-A1 | AZOLYLMETHYLOXIRANES, THEIR USE FOR CONTROLLING PHYTOPATHOGENIC FUNGI AND COMPOSITIONS COMPRISING THEM | BASF SE (DE) | 2009-03-18 | — | — | EP | disclosed |
| WO-2007147769-A1 | AZOLYLMETHYLOXIRANES, THEIR USE FOR CONTROLLING PHYTOPATHOGENIC FUNGI AND COMPOSITIONS COMPRISING THEM | BASF SE (DE) | 2007-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100167924-A1 | Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi and Compositions Comprising Them | PFAS, CBR3, CBR1 | CES2 2162/4885CES1 1067/4885GSK3B 4254/4885 |
| US-20120225777-A1 | Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi and Compositions Comprising Them | PFAS, CBR3, CBR1 | CES2 2175/4885CES1 1070/4885GSK3B 4291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.